Lobbying client
CEL-SCI CORPORATION
biotech co. in R&D of immunotherapy products for cancer,autoimmune,and infectious diseases
Filings
8
Filed by
1
Reported in-house
—
Reported by firms
$290,000
Reported lobbying by year
The larger of in-house and firm-reported each year, $ thousands
2019 to 2020
Filings
8 filings, newest first.
| Filing | Filed by | Amount |
|---|---|---|
|
4th Quarter - Termination 4th Quarter 2020
|
THE PETRIZZO GROUP, INC. | $40,000 reported |
|
3rd Quarter - Report 3rd Quarter 2020
|
THE PETRIZZO GROUP, INC. | $50,000 reported |
|
2nd Quarter - Report 2nd Quarter 2020
|
THE PETRIZZO GROUP, INC. | $50,000 reported |
|
1st Quarter - Report 1st Quarter 2020
|
THE PETRIZZO GROUP, INC. | $50,000 reported |
|
4th Quarter - Report 4th Quarter 2019
|
THE PETRIZZO GROUP, INC. | $50,000 reported |
|
3rd Quarter - Report 3rd Quarter 2019
|
THE PETRIZZO GROUP, INC. | $50,000 reported |
|
2nd Quarter - Report (No Activity) 2nd Quarter 2019
|
THE PETRIZZO GROUP, INC. | — reported |
|
Registration 2nd Quarter 2019
|
THE PETRIZZO GROUP, INC. | — reported |
Filed by
Each firm that has reported for this client, and the client itself where it lobbies in-house, with the reports filed and the amounts they disclose.
| Firm | Reports | Amount |
|---|---|---|
| THE PETRIZZO GROUP, INC. | 7 | $290,000 |
Issues lobbied
How many report sections named each issue, counting the current version of each report.
| Issue | Code | Mentions |
|---|---|---|
| Medical/Disease Research/Clinical Labs | MED | 7 |
| Health Issues | HCR | 1 |
From reports filed under the Lobbying Disclosure Act. Firms report what each client paid them; an organisation lobbying for itself reports its own expenses. Amounts count the current version of each report once.